Europe
Oculis completes subject enrolment in Phase III OCS-01 trial
The Phase III OPTIMIZE trial will assess the safety and efficacy of once-daily doses of OCS-01.
University of Birmingham reports new Phase II trial of exenatide for IIH
LEO Pharma and ICON partner for clinical trial execution in dermatology
AstraZeneca’s Imfinzi improves event-free survival in lung cancer trial
Alterity begins subject dosing in multiple system atrophy therapy trial
AB2 Bio concludes subject enrolment in trial of Tadekinig alfa for HLH
Calyx introduces new clinical trial supply forecasting service
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
